HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury.

Abstract
Dystrophin is an integral membrane protein involved in the stabilization of the sarcolemmal membrane in cardiac muscle. We hypothesized that the loss of membrane dystrophin during ischemia and reperfusion is responsible for contractile force-induced myocardial injury and that cardioprotection afforded by ischemic preconditioning (IPC) is related to the preservation of membrane dystrophin. Isolated and perfused rat hearts were subjected to 30 min of global ischemia, followed by reperfusion with or without the contractile blocker 2,3-butanedione monoxime (BDM). IPC was introduced by three cycles of 5-min ischemia and 5-min reperfusion before the global ischemia. Dystrophin was distributed exclusively in the membrane of myocytes in the normally perfused heart but was redistributed to the myofibril fraction after 30 min of ischemia and was lost from both of these compartments during reperfusion in the presence or absence of BDM. The loss of dystrophin preceded uptake of the membrane-impermeable Evans blue dye by myocytes that occurred after the withdrawal of BDM and was associated with creatine kinase release and the development of contracture. Although IPC did not alter the redistribution of membrane dystrophin induced by 30 min of ischemia, it facilitated the restoration of membrane dystrophin during reperfusion. Also, myocyte necrosis was not observed when BDM was withdrawn after complete restoration of membrane dystrophin. These results demonstrate that IPC-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contractile force-induced myocardial injury and suggest that the cardioprotection conferred by IPC can be enhanced by the temporary blockade of contractile activity until restoration of membrane dystrophin during reperfusion.
AuthorsMasakuni Kido, Hajime Otani, Shiori Kyoi, Tomohiko Sumida, Hiroyoshi Fujiwara, Takayuki Okada, Hiroji Imamura
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 287 Issue 1 Pg. H81-90 (Jul 2004) ISSN: 0363-6135 [Print] United States
PMID15001448 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Coloring Agents
  • Dystrophin
  • diacetylmonoxime
  • Evans Blue
  • Diacetyl
Topics
  • Animals
  • Coloring Agents (pharmacokinetics)
  • Diacetyl (administration & dosage, analogs & derivatives)
  • Dystrophin (metabolism)
  • Evans Blue (pharmacokinetics)
  • Ischemic Preconditioning, Myocardial
  • Male
  • Membranes (metabolism)
  • Myocardial Contraction
  • Myocardial Ischemia (metabolism)
  • Myocardial Reperfusion
  • Myocardial Reperfusion Injury (etiology, prevention & control)
  • Myocardium (metabolism)
  • Myocytes, Cardiac (metabolism, ultrastructure)
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: